Skip to Content

Alcon Inc

ALC: XSWX (CHE)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
CHF 44.00RcyjpWcdzqrvrz

Alcon Earnings: Strong Results Reaffirm Leadership in Surgical Market; Outlook Appears Solid

Narrow-moat Alcon reported fourth-quarter earnings that were better than our expectations. Total sales of $2.4 billion were up 8.3% year over year thanks to a strong performance from the ocular health and equipment business. After ticking up our near-term assumptions and accounting for time value of money impacts, we raised our fair value estimate to $70 per share from $64.

Free Trial of Morningstar Investor

Get our analysts’ objective, in-depth, and continuous investment coverage of ALC so you can make buy / sell decisions free of market noise.

Start Free Trial

Sponsor Center